(Q28265899)

Europe PubMed Central

PubMed ID

6323903

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6323903

28 September 2023

S. Antelman

2

1 reference

Europe PubMed Central

PubMed ID

6323903

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6323903

full work available at URL

28 September 2023

language of work or name

English

0 references

publication date

9 April 1984

0 references

https://api.elsevier.com/content/article/PII:0024320584900547?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

https://api.elsevier.com/content/article/PII:0024320584900547?httpAccept=text/plain

28 September 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

28 September 2023

0 references

34

0 references

page(s)

1403-13

0 references

issue

15

0 references

cites work

Vulnerability--a new view of schizophrenia

2

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Molecular pathology of schizophrenia: more than one disease process?

28 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

The dopamine hypothesis of schizophrenia revisited

28 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Biology of Schizophrenia Subtypes: A Review and Proposal for Method of Study

28 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

28 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

All-night sleep studies of acute schizophrenics.

28 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Stages of onset of schizophrenic psychosis

28 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

II. New evidence for a locus coeruleus-norepinephrine connection with anxiety

28 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Noradrenaline in the brain: progress in theories of behavioural function

28 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Dopaminergic mechanisms and cognitive deficit in schizophrenia. A neurobiological model

28 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Possible Etiology of Schizophrenia: Progressive Damage to the Noradrenergic Reward System by 6-Hydroxydopamine

28 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Norepinephrine-dopamine interactions and behavior

28 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Functional antagonism between dopamine and noradrenaline within the caudate nucleus of cats: A phenomenon of rhythmically changing susceptibility

28 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Effects of environmental change upon behavior of hospitalized schizophrenic patients

28 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Cognitive appraisal of stress and schizophrenic subtype.

28 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia

28 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

28 September 2023

23

17

233

Van Kammen

1982

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Long-term effects of teflutixol on the synthesis and endogenous levels of mouse brain catecholamines

28 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Determination of conjugated monoamine metabolites in brain tissue

28 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Central levels of noradrenaline, 3-methoxy-4-hydroxyphenylethyleneglycol and cyclic AMP in the rat after activation of Locus coeruleus neurons: Influence of single and repeated neuroleptic treatment

28 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Blockade by pimozide of a noradrenaline sensitive adenylate cyclase in the limbic forebrain: possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics

28 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: Metoclopramide, thiethylperazine, and molindone as pharmacological tools

28 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

28 September 2023

30

12

181

Freedman

1977

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Effects of clozapine on the activity of central dopaminergic and noradrenergic neurons

28 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Pharmacology and Neurochemistry of Apomorphine

28 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

28 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Brain Norepinephrine and Dopamine in Schizophrenia

28 September 2023

35

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

The activities of brain dopamine-?-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls

28 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Neurotransmitter Receptors in Frontal Cortex of Schizophrenics

28 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Schizophrenia: elevated cerebrospinal fluid norepinephrine

28 September 2023

43

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Noradrenergic Overactivity in Chronic Schizophrenia: Evidence Based on Cerebrospinal Fluid Noradrenaline and Cyclic Nucleotide Concentrations

28 September 2023

44

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

28 September 2023

45

17

711

Kemali

1982

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Cerebrospinal fluid MHPG. An assessment of norepinephrine metabolism in affective disorders.

28 September 2023

46

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

American Journal of Psychiatry

28 September 2023

47

157

174

Berger

1980

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia

28 September 2023

48

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Exploration of Affective Illness

28 September 2023

49

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

The effect of pimozide on CSF norepinephrine in schizophrenia

28 September 2023

53

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Central noradrenergic function in man: vanillylmandelic acid in CSF

28 September 2023

54

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

28 September 2023

55

13

685

Lerner

1978

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy

28 September 2023

57

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Long-term neuroleptic treatment of chronic schizophrenic patients: Clinical and biochemical effects of withdrawal

28 September 2023

58

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Plasma norepinephrine and dopamine-beta-hydroxylase activity in schizophrenia

28 September 2023

59

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Impaired Presynaptic Regulation of Norepinephrine in Schizophrenia

28 September 2023

62

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol

28 September 2023

63

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Determination of 3-methoxy-4-hydroxyphenylglycol conjugates in urine. Application to the study of central noradrenaline metabolism in unmedicated chronic schizophrenic patients

28 September 2023

64

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

3-Methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixol

28 September 2023

65

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Serum dopamine-beta-hydroxylase in schizophrenic patients

28 September 2023

66

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Serum dopamine-beta-hydroxylase in psychiatric patients and normals. Effect of d-amphetamine and haloperidol

28 September 2023

67

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients

28 September 2023

68

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Interactions of amphetamine, pimozide, and lithium on plasma norepinephrine and dopamine-beta- hydroxylase in schizophrenic patients

28 September 2023

69

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

28 September 2023

71

9

873

Delisi

1981

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

alpha-Adrenergic receptor function in schizophrenia. Receptor number, cyclic adenosine monophosphate production, adenylate cyclase activity, and effect of drugs

28 September 2023

72

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Reduced PGE1 stimulated 3H-cAMP accumulation in platelets from schizophrenics

28 September 2023

77

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Prostaglandins, platelets, and schizophrenia

28 September 2023

78

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Reduced cyclic AMP production in the blood platelets from schizophrenic patients

28 September 2023

79

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence

28 September 2023

83

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Mathematical Considerations in the Estimation of Peak Drug Concentrations Under Uniform and Nonuniform Dosing Conditions

28 September 2023

84

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

The locus coeruleus: neurobiology of a central noradrenergic nucleus

28 September 2023

86

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Dopamine beta-hydroxylase in CSF. Relationship to personality measures.

28 September 2023

87

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Schizophrenia: Dopamine β-Hydroxylase Activity and Treatment Response

28 September 2023

89

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Cytomegalovirus Antibody in Cerebrospinal Fluid of Schizophrenic Patients Detected by Enzyme Immunoassay

28 September 2023

93

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

The offspring of schizophrenics. Fetal and neonatal deaths

28 September 2023

94

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Regional cerebral blood flow in schizophrenics. Tests using the xenon Xe 133 inhalation method

28 September 2023

95

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Psychophysiological study of mentally ill patients; the status of the peripheral autonomic nervous system as determined by the reaction to epinephrine and mecholyl.

28 September 2023

96

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Nor-epinephrine-like and epinephrine-like substances in psychotic and psychoneurotic patients.

28 September 2023

97

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Influence of endogenous norepinephrine on cerebral blood flow and metabolism

28 September 2023

98

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Autonomic nervous system activity in acute schizophrenia: I. method and comparison with normal controls.

28 September 2023

99

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Situational reactivity of autonomic functions in schizophrenic patients.

28 September 2023

100

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

28 September 2023

101

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Hypoarousal in patients with the neglect syndrome and emotional indifference

28 September 2023

102

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

Urinary catecholamine metabolites and effects of clonidine in patients with alcohol amnestic disorder

28 September 2023

104

1 reference

https://api.crossref.org/works/10.1016/0024-3205(84)90054-7

28 September 2023

Identifiers

1 reference

Consolidated OpenCitations Corpus – April 2017

1665834

1665834

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference